TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17937837

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 0
Study: 15142328

Group type: EXPERIMENTAL
Intervention: Echovist‐300 without VM
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Echovist‐300, VM for 5 seconds
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Repetitive short VMs after Echovist‐300 injection
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Repetitive short VMs after agitated saline injection
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Threshold of two or three microbubbles
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: TCD using Echovist‐300
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Repetitive VM
Number of subjects: 71
Study: 11206674

Group type: EXPERIMENTAL
Intervention: Carvedilol 50 mg once daily for 16 weeks
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Valsartan 80 mg once daily for 16 weeks
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo for 16 weeks
Number of subjects: 160
Study: 9534010

Group type: EXPERIMENTAL
Intervention: Benfluorex (3 tablets daily)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 7831993

Group type: EXPERIMENTAL
Intervention: Lower neuroleptic doses in the suicide group
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Previous suicide attempts
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Positive schizophrenic symptoms
Number of subjects: 56
Study: 3049861

Group type: EXPERIMENTAL
Intervention: Topically applied ophthalmic solution containing trimethoprim and polymyxin B (TP)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Topically applied ophthalmic solution containing trimethoprim, polymyxin B, and sulfacetamide
Number of subjects: 39
Study: 29334997

Group type: EXPERIMENTAL
Intervention: Weekly self-monitoring of blood glucose (4-point glucose measurements before meals and bedtime)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Every 2 weeks self-monitoring of blood glucose (4-point glucose measurements before meals and bedtime)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Monthly self-monitoring of blood glucose (4-point glucose measurements before meals and bedtime)
Number of subjects: 58
Study: 27729073

Group type: EXPERIMENTAL
Intervention: pCGS plus diacerein
Number of subjects: 148

Group type: COMPARATOR
Intervention: pCGS plus placebo
Number of subjects: 148
Study: 25023711

Group type: EXPERIMENTAL
Intervention: CT-guided nucleoplasty
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: CT-guided nucleoplasty with nerve root injection
Number of subjects: 97

Group type: COMPARATOR
Intervention: CT-guided transforaminal lumbar epidural injections
Number of subjects: 97
Study: 24251833

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 20883054

Group type: EXPERIMENTAL
Intervention: Pneumococcal polysaccharide conjugate vaccine Prevenar 13 (PCV13)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Booster dose of PCV13
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PCV13 as catch-up vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PCV13
Number of subjects: 0
Study: 18833509

Group type: EXPERIMENTAL
Intervention: Dilute epinephrine (1 : 20 000)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 40
Study: 16787962

Group type: EXPERIMENTAL
Intervention: DHEA + exercise
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo + exercise
Number of subjects: 56
Study: 12880881

Group type: EXPERIMENTAL
Intervention: Weight concerns
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 367
Study: 15465543

Group type: EXPERIMENTAL
Intervention: Multifocal IOLs
Number of subjects: 153

Group type: COMPARATOR
Intervention: Monofocal IOLs
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Both IOLs
Number of subjects: 153
Study: 10079445

Group type: EXPERIMENTAL
Intervention: PRK
Number of subjects: 220

Group type: COMPARATOR
Intervention: LASIK
Number of subjects: 220
Study: 7673497

Group type: EXPERIMENTAL
Intervention: Antiperspirant with emollient additives (20% aluminum zirconium tetrachlorohydrex glycine concentration plus water)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Emollient additives alone (placebo control)
Number of subjects: 23

Group type: COMPARATOR
Intervention: No treatment (nontreated)
Number of subjects: 23
Study: 2123882

Group type: EXPERIMENTAL
Intervention: buserelin/HMG
Number of subjects: 31

Group type: COMPARATOR
Intervention: HMG
Number of subjects: 31
Study: 6116607

Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg plus whisky 100 ml
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 31860599

Group type: EXPERIMENTAL
Intervention: Propofol TCI with esketamine (group E)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Propofol TCI with alfentanil (group A)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Both groups (E and A)
Number of subjects: 162
Study: 27880064

Group type: EXPERIMENTAL
Intervention: Group Cognitive Behavioural Therapy (Group-CBT) for 8 weeks
Number of subjects: 51

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 51
Study: 25935314

Group type: EXPERIMENTAL
Intervention: Acceptance & Commitment group Therapy (ACT-G), n=63
Number of subjects: 126

Group type: COMPARATOR
Intervention: Waitlist, n=63
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Untreated patients with severe HA
Number of subjects: 126
Study: 23324658

Group type: EXPERIMENTAL
Intervention: Long-lasting insecticide-treated bed nets and water filters
Number of subjects: 589

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 589
Study: 21362011

Group type: EXPERIMENTAL
Intervention: Oral hygiene protocol implemented in 7 nursing homes
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (7 nursing homes)
Number of subjects: 14
Study: 19761353

Group type: EXPERIMENTAL
Intervention: Prophylactic oral lamivudine 100 mg/day before and until at least 6 months after transplantation
Number of subjects: 32

Group type: COMPARATOR
Intervention: High-dose chemotherapy and AHSCT without lamivudine (historical control group)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Prophylactic oral lamivudine 100 mg/day
Number of subjects: 32
Study: 18688944

Group type: EXPERIMENTAL
Intervention: Azithromycin (1000 mg) plus loperamide
Number of subjects: 207

Group type: COMPARATOR
Intervention: Levofloxacin (500 mg) plus loperamide
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Azithromycin (1000 mg)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Levofloxacin (500 mg)
Number of subjects: 207
Study: 15318711

Group type: EXPERIMENTAL
Intervention: 4 fractions of 6.5 Gy each (overall dosage‐‐26 Gy) (2 fractions per week)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: 5 fractions of 6.5 Gy each (overall dosage‐‐32.5 Gy) (2 fractions per week)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: 4 daily fractions of 6.5 Gy each (overall dosage‐‐26 Gy)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: 23 fractions (overall dosage‐‐46 Gy) (5 weekly fractions)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Standard low‐dosage fractionated irradiation
Number of subjects: 167
Study: 11531213

Group type: EXPERIMENTAL
Intervention: Structured triglyceride emulsion
Number of subjects: 25

Group type: COMPARATOR
Intervention: Physical mixture of medium- and long-chain triglycerides
Number of subjects: 25
Study: 9763719

Group type: EXPERIMENTAL
Intervention: Blister packaging of antimalarial drugs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional means of dispensing antimalarial drugs (paper envelope)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3-day chloroquine course in blister packs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 8-day primaquine course in blister packs
Number of subjects: 0
Study: 7512805

Group type: EXPERIMENTAL
Intervention: Antihistamine treatment with dimetindene (0.2 mg/kg) and ranitidine (1.25 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group receiving saline
Number of subjects: 40
Study: 3125026

Group type: EXPERIMENTAL
Intervention: 100 micrograms of misoprostol
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 200 micrograms of misoprostol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 30987883

Group type: EXPERIMENTAL
Intervention: 360° VR test
Number of subjects: 28

Group type: COMPARATOR
Intervention: Match broadcast test
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both video modes
Number of subjects: 28
Study: 26211735

Group type: EXPERIMENTAL
Intervention: 2% lavender essential oil via inhalation for 15 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no inhalation of lavender essential oil)
Number of subjects: 60
Study: 25762359

Group type: EXPERIMENTAL
Intervention: FDIS + metronidazole
Number of subjects: 184

Group type: COMPARATOR
Intervention: FDIS + placebo
Number of subjects: 184

Group type: COMPARATOR
Intervention: SRP + metronidazole
Number of subjects: 184

Group type: COMPARATOR
Intervention: SRP + placebo
Number of subjects: 184
Study: 22858212

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 25
Study: 20827548

Group type: EXPERIMENTAL
Intervention: teriparatide
Number of subjects: 203
Study: 19671398

Group type: EXPERIMENTAL
Intervention: Healthy school meal (25-30% of daily caloric intake) for two months
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 145
Study: 17453751

Group type: EXPERIMENTAL
Intervention: Work day
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non-work day
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both work and non-work days
Number of subjects: 80
Study: 15689645

Group type: EXPERIMENTAL
Intervention: Store-and-forward teledermatology consult system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 11926784

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 2419
Study: 10086815

Group type: EXPERIMENTAL
Intervention: Delphi consensus technique
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Delphi list
Number of subjects: 21
Study: 7777295

Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil (5-FU) filtering surgery
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Patients aged 50 years or younger
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Patients older than 50 years of age
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Type 1 diabetes
Number of subjects: 34
Study: 2577280

Group type: EXPERIMENTAL
Intervention: Timolol (10 mg b.i.d. for 5 days)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg b.i.d. for 5 days)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Beta blockade (timolol and metoprolol)
Number of subjects: 20
Study: 712004

Group type: EXPERIMENTAL
Intervention: Male voices
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Female voices
Number of subjects: 20
Study: 31837886

Group type: EXPERIMENTAL
Intervention: Coffee consumption (drinking an extra cup of coffee per day)
Number of subjects: 227666
Study: 30720034

Group type: EXPERIMENTAL
Intervention: Daily fresh pear consumption (2 medium-sized pears per day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Calorie-matched control drink
Number of subjects: 40
Study: 28865866

Group type: EXPERIMENTAL
Intervention: Water-based resistance-aerobic (RA) sequence
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Water-based aerobic-resistance (AR) sequence
Number of subjects: 13
Study: 26034956

Group type: EXPERIMENTAL
Intervention: Bundled intervention including mupirocin intranasally twice daily for up to 5 days, chlorhexidine-gluconate bathing for up to 5 days, and perioperative prophylaxis with vancomycin and cefazolin or cefuroxime for MRSA carriers; cefazolin or cefuroxime for others.
Number of subjects: 42534

Group type: COMPARATOR
Intervention: Preintervention period without the bundled intervention.
Number of subjects: 42534
Study: 23230306

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement
Number of subjects: 955

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 955

Group type: EXPERIMENTAL
Intervention: Surgical valve replacement
Number of subjects: 955
Study: 21576282

Group type: EXPERIMENTAL
Intervention: Nesiritide (NES)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Nitroglycerin (NTG)
Number of subjects: 89
Study: 19144937

Group type: COMPARATOR
Intervention: Angiography-guided PCI
Number of subjects: 1005

Group type: EXPERIMENTAL
Intervention: FFR-guided PCI
Number of subjects: 1005
Study: 16829773

Group type: EXPERIMENTAL
Intervention: Nursing involvement in tobacco cessation
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Experimental research designs
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Quasi-experimental research designs
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Descriptive-quantitative research designs
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Descriptive-qualitative research designs
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Meta-analyses
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Secondary analyses and systematic reviews
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Nursing journals
Number of subjects: 175
Study: 15330029

Group type: EXPERIMENTAL
Intervention: Ilizarov ring fixator
Number of subjects: 60

Group type: COMPARATOR
Intervention: Monolateral articulated external fixator
Number of subjects: 60
Study: 12063773

Group type: COMPARATOR
Intervention: Step Two diet
Number of subjects: 132

Group type: COMPARATOR
Intervention: Lovastatin (up to 40 mg/day)
Number of subjects: 132
Study: 9304634

Group type: COMPARATOR
Intervention: 5 ml of local anesthetic (2% lidocaine, 0.75% bupivacaine hydrochloride, and 1500 IU of hyaluronidase)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: 7 ml of local anesthetic (2% lidocaine, 0.75% bupivacaine hydrochloride, and 1500 IU of hyaluronidase)
Number of subjects: 85
Study: 8141715

Group type: EXPERIMENTAL
Intervention: Intravenous heparin with streptokinase (SK)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subcutaneous heparin with streptokinase (SK)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tissue plasminogen activator (t-PA)
Number of subjects: 0
Study: 2896506

Group type: EXPERIMENTAL
Intervention: Propranolol 2 X 40 mg p.o.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Betaxolol (Kerlone) 20 mg p.o.
Number of subjects: 20
Study: 30320560

Group type: EXPERIMENTAL
Intervention: Pre-CAS group (300 mg of clopidogrel before stenting)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Post-CAS group (300 mg of clopidogrel after stenting)
Number of subjects: 13
Study: 29928776

Group type: EXPERIMENTAL
Intervention: Weight-specified dose of alcohol (0.7 g alcohol/kg body weight)
Number of subjects: 143
Study: 26207570

Group type: EXPERIMENTAL
Intervention: Legal prime
Number of subjects: 268

Group type: COMPARATOR
Intervention: Case vignette alone (Control)
Number of subjects: 268
Study: 24660834

Group type: EXPERIMENTAL
Intervention: Echocardiography-guided hemodynamic management (EGHEM)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 28
Study: 22119513

Group type: EXPERIMENTAL
Intervention: E2 (0.05 or 0.1 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 24
Study: 20096066

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) combined with a bovine-derived xenograft (BDX)
Number of subjects: 24
Study: 18844269

Group type: EXPERIMENTAL
Intervention: 0.6 ml of a solution containing 30 units botulinum toxin
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.6 ml saline (placebo)
Number of subjects: 30
Study: 15031571

Group type: EXPERIMENTAL
Intervention: 5 mg nebivolol
Number of subjects: 20

Group type: COMPARATOR
Intervention: 30 mg nifedipine GITS
Number of subjects: 20
Study: 11522047

Group type: EXPERIMENTAL
Intervention: Amiodarone (200 mg four times daily as a loading dose)
Number of subjects: 9
Study: 9735578

Group type: EXPERIMENTAL
Intervention: Multidimensional Treatment Foster Care (MTFC)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Group Care (GC)
Number of subjects: 79
Study: 8296409

Group type: EXPERIMENTAL
Intervention: 20 micrograms ethinyl estradiol and 150 micrograms desogestrel (n = 15)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 30 micrograms ethinyl estradiol and 75 micrograms gestodene (n = 19)
Number of subjects: 34
Study: 2737789

Group type: EXPERIMENTAL
Intervention: EpiDx (720 mg/m2, 60 mg/m2 every 3 weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Doxorubicin (Dx) (540 mg/m2, 60 mg/m2 every 3 weeks)
Number of subjects: 22
Study: 820882

Group type: EXPERIMENTAL
Intervention: Cromolyn
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 31977827

Group type: EXPERIMENTAL
Intervention: psychiatry + meditation (n = 8)
Number of subjects: 28

Group type: COMPARATOR
Intervention: psychiatry only (n = 10)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: meditation only (n = 8)
Number of subjects: 28
Study: 30367848

Group type: EXPERIMENTAL
Intervention: Geriatrician-performed comprehensive geriatric care
Number of subjects: 368

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 368
Study: 28865981

Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Standard Dressing
Number of subjects: 102
Study: 26388152

Group type: EXPERIMENTAL
Intervention: Central PET interpretation
Number of subjects: 739

Group type: COMPARATOR
Intervention: Local PET interpretation
Number of subjects: 739

Group type: EXPERIMENTAL
Intervention: Central PET review panel
Number of subjects: 739

Group type: EXPERIMENTAL
Intervention: Therapeutic regime based on central panel decision
Number of subjects: 739
Study: 23663109

Group type: EXPERIMENTAL
Intervention: Epilepsy patients
Number of subjects: 288
Study: 21874272

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation during the third trimester of pregnancy
Number of subjects: 533

Group type: COMPARATOR
Intervention: Olive oil supplementation during the third trimester of pregnancy
Number of subjects: 533

Group type: COMPARATOR
Intervention: No oil supplementation during the third trimester of pregnancy
Number of subjects: 533
Study: 19083556

Group type: EXPERIMENTAL
Intervention: Pregabalin 75 mg, twice daily in addition to 5‐mg hydrocodone tablets as needed
Number of subjects: 80

Group type: COMPARATOR
Intervention: 5‐mg hydrocodone tablets as needed
Number of subjects: 80
Study: 16868063

Group type: EXPERIMENTAL
Intervention: Flutamide (250 mg, orally, twice a day)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg, orally, twice a day)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Combination of metformin and flutamide
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 12601103

Group type: EXPERIMENTAL
Intervention: High serum PTH group (female stroke patients with serum PTH level higher than mean + 2 SD of control subjects)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Normal PTH group (female stroke patients with serum PTH level within normal range)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (107 healthy volunteers matched for age and sex)
Number of subjects: 107
Study: 11775043

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 9832970

Group type: EXPERIMENTAL
Intervention: Triazolam (0.125, 0.25, and 0.5 mg/70 kg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Zolpidem (5, 10, and 20 mg/70 kg)
Number of subjects: 11
Study: 8493470

Group type: EXPERIMENTAL
Intervention: Traditional Chinese acupuncture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transcutaneous nerve stimulation (TENS) of the tibial nerve
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 3484704

Group type: EXPERIMENTAL
Intervention: St. Thomas Hospital cardioplegia (myocardial temperature below 16 degrees C)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Intermittent aortic cross‐clamping at 34 degrees C
Number of subjects: 72

Group type: COMPARATOR
Intervention: Intermittent aortic cross‐clamping at 25 degrees C
Number of subjects: 72
Study: 30545995

Group type: EXPERIMENTAL
Intervention: Clinician-reported all-grade AEs
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Clinician-reported severity score
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Total number of high-grade AEs
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Patient-reported scores
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Patient-reported cumulative toxicity scores
Number of subjects: 385
Study: 26791023

Group type: EXPERIMENTAL
Intervention: Planning intervention
Number of subjects: 1158

Group type: EXPERIMENTAL
Intervention: Implementation intention intervention
Number of subjects: 1158

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 1158
Study: 24769189

Group type: EXPERIMENTAL
Intervention: Attend to Pain
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Avoid Pain
Number of subjects: 62
Study: 22791533

Group type: EXPERIMENTAL
Intervention: Weekly direct observation with formal feedback (DO-FF)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 14
Study: 20925544

Group type: EXPERIMENTAL
Intervention: Rolofylline (30 mg daily intravenous for up to 3 days)
Number of subjects: 2033

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2033
Study: 18194384

Group type: EXPERIMENTAL
Intervention: Single-dose lenograstim (5 microg per kg once daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Split-dose lenograstim (2.5 microg per kg twice daily)
Number of subjects: 40
Study: 15993933

Group type: EXPERIMENTAL
Intervention: Celecoxib (400 mg/day) for 3 months prior to surgery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 12847809

Group type: EXPERIMENTAL
Intervention: Kan-Yang tablets
Number of subjects: 53

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 53